{"id":"https://openalex.org/W3096649754","doi":"https://doi.org/10.1158/1538-7445.tumhet2020-po-117","title":"Abstract PO-117: CHD1-loss promotes tumor heterogeneity and therapy resistance in prostate cancer","display_name":"Abstract PO-117: CHD1-loss promotes tumor heterogeneity and therapy resistance in prostate cancer","publication_year":2020,"publication_date":"2020-11-01","ids":{"openalex":"https://openalex.org/W3096649754","doi":"https://doi.org/10.1158/1538-7445.tumhet2020-po-117","mag":"3096649754"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.tumhet2020-po-117","doi":"https://doi.org/10.1158/1538-7445.tumhet2020-po-117","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.tumhet2020-po-117","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024562035","display_name":"Zeda Zhang","orcid":"https://orcid.org/0000-0002-7225-534X","observed_orcids":["https://orcid.org/0000-0002-7225-534X"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zeda Zhang","raw_affiliation_strings":["1Memorial Sloan Kettering Cancer Center, New York, NY,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Memorial Sloan Kettering Cancer Center, New York, NY,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101782498","display_name":"Chuanli Zhou","orcid":"https://orcid.org/0000-0003-1848-2055","observed_orcids":["https://orcid.org/0000-0003-1848-2055"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chuanli Zhou","raw_affiliation_strings":["2UT Southwestern Medical Center, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2UT Southwestern Medical Center, Dallas, TX","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100369487","display_name":"Xiaoling Li","orcid":"https://orcid.org/0000-0002-1554-1569","observed_orcids":["https://orcid.org/0000-0002-1554-1569","https://orcid.org/0009-0008-4569-0857"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaoling Li","raw_affiliation_strings":["2UT Southwestern Medical Center, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2UT Southwestern Medical Center, Dallas, TX","institution_ids":["https://openalex.org/I867280407"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034963668","display_name":"Charles L. Sawyers","orcid":"https://orcid.org/0000-0003-4955-6475","observed_orcids":["https://orcid.org/0000-0003-4955-6475"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles Sawyers","raw_affiliation_strings":["1Memorial Sloan Kettering Cancer Center, New York, NY,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Memorial Sloan Kettering Cancer Center, New York, NY,","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067011080","display_name":"Ping Mu","orcid":"https://orcid.org/0000-0003-0955-0896","observed_orcids":["https://orcid.org/0000-0003-0955-0896"]},"institutions":[{"id":"https://openalex.org/I867280407","display_name":"The University of Texas Southwestern Medical Center","ror":"https://ror.org/05byvp690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I867280407"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ping Mu","raw_affiliation_strings":["2UT Southwestern Medical Center, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2UT Southwestern Medical Center, Dallas, TX","institution_ids":["https://openalex.org/I867280407"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"80","issue":"21_Supplement","first_page":"PO","last_page":"117"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chd1","display_name":"CHD1","score":0.9679999947547913},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.8270000219345093},{"id":"https://openalex.org/keywords/androgen-receptor","display_name":"androgen receptor","score":0.7990000247955322},{"id":"https://openalex.org/keywords/enzalutamide-resistance","display_name":"enzalutamide resistance","score":0.9520000219345093},{"id":"https://openalex.org/keywords/copy-number-alterations","display_name":"copy number alterations","score":0.8289999961853027},{"id":"https://openalex.org/keywords/tumor-heterogeneity","display_name":"tumor heterogeneity","score":0.8579999804496765},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.6800000071525574},{"id":"https://openalex.org/keywords/chromatin-state","display_name":"chromatin state","score":0.6930000185966492},{"id":"https://openalex.org/keywords/gr","display_name":"GR","score":0.47699999809265137},{"id":"https://openalex.org/keywords/brn2","display_name":"Brn2","score":0.9679999947547913},{"id":"https://openalex.org/keywords/nr2f1","display_name":"NR2F1","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tbx2","display_name":"TBX2","score":0.9990000128746033},{"id":"https://openalex.org/keywords/transcriptional-heterogeneity","display_name":"transcriptional heterogeneity","score":0.8040000200271606},{"id":"https://openalex.org/keywords/androgen-receptor-targeted-therapy","display_name":"androgen receptor-targeted therapy","score":0.628000020980835}],"concepts":[{"id":"https://openalex.org/C2776551883","wikidata":"https://www.wikidata.org/wiki/Q1996756","display_name":"Enzalutamide","level":5,"score":0.8510606288909912},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7691144347190857},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6113355159759521},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5986524820327759},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5699566602706909},{"id":"https://openalex.org/C83640560","wikidata":"https://www.wikidata.org/wiki/Q180951","display_name":"Chromatin","level":3,"score":0.5632803440093994},{"id":"https://openalex.org/C179138559","wikidata":"https://www.wikidata.org/wiki/Q24740158","display_name":"Chromodomain","level":5,"score":0.5202123522758484},{"id":"https://openalex.org/C205003668","wikidata":"https://www.wikidata.org/wiki/Q17113442","display_name":"Chromoplexy","level":5,"score":0.44967132806777954},{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.44760555028915405},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.3596852123737335},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.3423013985157013},{"id":"https://openalex.org/C61367390","wikidata":"https://www.wikidata.org/wiki/Q416601","display_name":"Androgen receptor","level":4,"score":0.3133385181427002},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.14889273047447205},{"id":"https://openalex.org/C67705224","wikidata":"https://www.wikidata.org/wiki/Q11053","display_name":"RNA","level":3,"score":0.14604344964027405},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.1414339542388916},{"id":"https://openalex.org/C87874733","wikidata":"https://www.wikidata.org/wiki/Q18039844","display_name":"PCA3","level":4,"score":0.09423115849494934},{"id":"https://openalex.org/C161223559","wikidata":"https://www.wikidata.org/wiki/Q138864","display_name":"Helicase","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.tumhet2020-po-117","doi":"https://doi.org/10.1158/1538-7445.tumhet2020-po-117","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.tumhet2020-po-117","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3014035083","https://openalex.org/W4362593196","https://openalex.org/W3096208880","https://openalex.org/W4213281156","https://openalex.org/W3083636874","https://openalex.org/W2886876420","https://openalex.org/W2491020891","https://openalex.org/W4282982152","https://openalex.org/W4409415643","https://openalex.org/W7130514201"],"abstract_inverted_index":{"Abstract":[0],"Targeted":[1],"therapies":[2],"for":[3,25,123,326],"driver":[4,45],"oncogenes":[5],"have":[6],"transformed":[7],"the":[8,14,26,30,38,43,58,61,93,104,108,132,195,254,267,293,308,327,389],"management":[9],"of":[10,18,32,40,164,197,200,213,289,295,302,388],"many":[11],"cancers":[12],"but":[13,336],"magnitude":[15],"and":[16,78,130,181,191,215,252,315,379],"duration":[17],"response":[19,28],"remains":[20],"variable.":[21],"One":[22],"potential":[23],"explanation":[24,325],"various":[27],"is":[29,60,70,155],"presence":[31],"additional":[33],"genomic":[34,77,82],"alterations":[35,85,111],"which":[36,87,230,306],"modify":[37],"degree":[39],"dependence":[41],"on":[42,284,394],"targeted":[44,97,297,361],"mutation.":[46],"Metastatic":[47],"castration":[48],"resistant":[49,250,271],"prostate":[50,121,169,383],"cancer":[51,122,170,384],"(mCRPC)":[52],"serves":[53],"as":[54,139],"an":[55,201,323],"example,":[56],"where":[57],"target":[59],"androgen":[62],"receptor":[63],"(AR).":[64],"Compared":[65],"to":[66,90,92,95,176,353,400],"primary":[67],"disease,":[68],"mCRPC":[69,260,334],"characterized":[71],"by":[72,107,148],"extensive":[73],"heterogeneity":[74,244,331,378],"at":[75],"both":[76,178],"transcriptional":[79,243,330],"levels,":[80],"including":[81],"copy":[83,109],"number":[84,110],"(CNAs),":[86],"are":[88,231],"presumed":[89],"contribute":[91],"resistance":[94,129,175,224,299,346,358,381],"AR":[96,296,316,360],"therapies.":[98,362],"To":[99],"gain":[100],"functional":[101],"insight":[102],"into":[103],"genes":[105,117],"impacted":[106],"in":[112,120,127,166,179,182,189,208,233,247,253,270,333,382],"mCRPC,":[113],"we":[114,185],"screened":[115],"730":[116],"often":[118],"deleted":[119],"CNAs":[124],"that":[125,152,291,339],"confer":[126],"vivo":[128],"identified":[131,221],"chromodomain":[133],"helicase":[134],"DNA-binding":[135],"protein":[136],"1":[137],"(CHD1)":[138],"a":[140,145,258,287,350],"top":[141],"candidate":[142],"modifying":[143],"resistance,":[144],"finding":[146],"supported":[147],"patient":[149],"data":[150],"showing":[151],"CHD1":[153,165],"expression":[154],"inversely":[156],"correlated":[157],"with":[158,205,218,273],"clinical":[159,341],"benefit":[160],"from":[161,257,311],"therapy.":[162],"Depletion":[163],"multiple":[167],"human":[168],"cell":[171],"lines":[172],"confers":[173],"significant":[174],"enzalutamide":[177,268],"vitro":[180],"vivo.":[183],"Furthermore,":[184],"observed":[186,246,332],"global":[187,282],"changes":[188,207],"open":[190],"closed":[192],"chromatin":[193,203],"after":[194],"depletion":[196],"CHD1,":[198],"indicative":[199],"altered":[202],"state,":[204],"associated":[206],"gene":[209],"expression.":[210],"Integrative":[211],"analysis":[212],"ATAC-seq":[214],"RNA-seq,":[216],"combining":[217],"CRISPR-based":[219],"screen,":[220],"four":[222],"heterogenous":[223,345],"drivers":[225,347],"(GR,":[226],"BRN2,":[227],"NR2F1,":[228],"TBX2),":[229],"elevated":[232,274],"different":[234],"independently":[235],"derived,":[236],"enzalutamide-resistant,":[237],"CHD1-deleted":[238],"subclones.":[239],"Importantly,":[240],"significantly":[241,328],"increased":[242,329],"was":[245],"these":[248,344],"CHD1-depleted":[249],"tumors":[251,272],"tumor":[255,377],"samples":[256],"large":[259],"patients\u2019":[261],"cohort.":[262],"Finally,":[263],"GR":[264,275],"inhibition":[265],"restored":[266],"sensitiivty":[269],"signaling.":[276],"These":[277],"results":[278],"suggest":[279],"CHD1-loss,":[280],"through":[281,300],"effects":[283],"chromatin,":[285],"establishes":[286],"state":[288],"plasticity":[290],"accelerates":[292],"development":[294],"therapy":[298,380],"activation":[301],"heterogeneous":[303],"downstream":[304],"effectors,":[305],"mediated":[307],"transition":[309],"away":[310],"luminal":[312],"lineage":[313],"identity":[314],"dependency.":[317],"This":[318],"model":[319],"not":[320],"only":[321],"provides":[322],"innovative":[324],"patients,":[335],"also":[337],"suggests":[338],"proper":[340],"interventions":[342],"targeting":[343],"may":[348],"be":[349],"novel":[351],"avenue":[352],"prevent":[354],"or":[355],"even":[356],"reverse":[357],"towards":[359],"Citation":[363],"Format:":[364],"Zeda":[365],"Zhang,":[366],"Chuanli":[367],"Zhou,":[368],"Xiaoling":[369],"Li,":[370],"Charles":[371],"Sawyers,":[372],"Ping":[373],"Mu.":[374],"CHD1-loss":[375],"promotes":[376],"[abstract].":[385],"In:":[386],"Proceedings":[387],"AACR":[390],"Virtual":[391],"Special":[392],"Conference":[393],"Tumor":[395],"Heterogeneity:":[396],"From":[397],"Single":[398],"Cells":[399],"Clinical":[401],"Impact;":[402],"2020":[403],"Sep":[404],"17-18.":[405],"Philadelphia":[406],"(PA):":[407],"AACR;":[408],"Cancer":[409],"Res":[410],"2020;80(21":[411],"Suppl):Abstract":[412],"nr":[413],"PO-117.":[414]},"counts_by_year":[],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2020-11-09T00:00:00"}